Correction: Invitrogen Suit Against GE Healthcare Transferred to Texas

The suit alleges infringement of patents covering reverse transcriptase technology, and is in addition to a suit Invitrogen filed against GE last year for alleged infringement.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.